OBJECTIVE: Under some circumstances the HIV virus may infect cells that do not express receptors essential to HIV-entry. We hypothesized that platelet- and megakaryocyte-derived microparticles (MP) could play a role in such infections. MP are circular membrane fragments shed from the surface of eukaryotic cells. After adhesion to target cells, MP may transfer membrane-associated proteins to these cells. We found that peripheral blood platelet- (PMP) and megakaryocyte-derived MP (MegaMP) that highly express CXCR4 may transfer this receptor from the surface of platelets or megakaryocytes to the surface of CXCR4-null cells. DESIGN: Since this mechanism could potentially allow CD4+/CXCR4-null cells to become infected by T-tropic HIV, we incubated several human CD4+/CXCR4-null cells such as normal erythroblasts, glioblastomas U87, MAGI and hematopoietic cell lines UT-7, HEL and TF-1 with PMP or MegaMP. We found that these cells became CXCR4+. We next exposed these cells to X4-HIV (IIIB) and evaluated their susceptibility to infection by PCR, ELISA, and morphological analysis. RESULTS: We observed in all instances that after CD4+/CXCR4-null cell lines 'acquired' CXCR4 from PMP or MegaMP, they could became infected by X4 HIV. CONCLUSIONS: We postulate that both PMP and MegaMP may play a novel and important role in spreading HIV-1 infection by transferring the CXCR4 co-receptor to CD4+/CXCR4-null cells.
OBJECTIVE: Under some circumstances the HIV virus may infect cells that do not express receptors essential to HIV-entry. We hypothesized that platelet- and megakaryocyte-derived microparticles (MP) could play a role in such infections. MP are circular membrane fragments shed from the surface of eukaryotic cells. After adhesion to target cells, MP may transfer membrane-associated proteins to these cells. We found that peripheral blood platelet- (PMP) and megakaryocyte-derived MP (MegaMP) that highly express CXCR4 may transfer this receptor from the surface of platelets or megakaryocytes to the surface of CXCR4-null cells. DESIGN: Since this mechanism could potentially allow CD4+/CXCR4-null cells to become infected by T-tropic HIV, we incubated several humanCD4+/CXCR4-null cells such as normal erythroblasts, glioblastomasU87, MAGI and hematopoietic cell lines UT-7, HEL and TF-1 with PMP or MegaMP. We found that these cells became CXCR4+. We next exposed these cells to X4-HIV (IIIB) and evaluated their susceptibility to infection by PCR, ELISA, and morphological analysis. RESULTS: We observed in all instances that after CD4+/CXCR4-null cell lines 'acquired' CXCR4 from PMP or MegaMP, they could became infected by X4 HIV. CONCLUSIONS: We postulate that both PMP and MegaMP may play a novel and important role in spreading HIV-1 infection by transferring the CXCR4 co-receptor to CD4+/CXCR4-null cells.
Authors: Jason M Aliotta; David Lee; Napoleon Puente; Sam Faradyan; Edmund H Sears; Ashley Amaral; Laura Goldberg; Mark S Dooner; Mandy Pereira; Peter J Quesenberry Journal: Stem Cells Dev Date: 2012-02-15 Impact factor: 3.272
Authors: Jason M Aliotta; Fermin M Sanchez-Guijo; Gerri J Dooner; Kevin W Johnson; Mark S Dooner; Kenneth A Greer; Deborah Greer; Jeffrey Pimentel; Luiz M Kolankiewicz; Napoleon Puente; Sam Faradyan; Paulette Ferland; Elaine L Bearer; Michael A Passero; Mehrdad Adedi; Gerald A Colvin; Peter J Quesenberry Journal: Stem Cells Date: 2007-06-07 Impact factor: 6.277
Authors: Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff Journal: Blood Date: 2008-01-15 Impact factor: 22.113
Authors: Ali Danesh; Heather C Inglis; Rachael P Jackman; Shiquan Wu; Xutao Deng; Marcus O Muench; John W Heitman; Philip J Norris Journal: Blood Date: 2013-12-12 Impact factor: 22.113